Immune System News and Research

RSS

COVID vaccines have only 17% detectable antibodies against SARS-CoV-2 virus

When clinical trials were conducted to determine the immunogenicity -- the ability to elicit an immune response -- for the first two vaccines marshaled against SARS-CoV-2the virus that causes COVID-19, one group was not among those included: people who have received solid organ transplants and others (such as those with autoimmune disorders) who are immunocompromised.

25 Mar 2021

New therapeutic vaccine uses patient's own tumor cells to aid in cancer destruction

Immunotherapy, which recruits the body's own immune system to attack cancer, has given many cancer patients a new avenue to treat the disease.

24 Mar 2021

Researchers characterize a potential therapeutic target to weaken COVID-19

When invaded by a virus, our body cells launch an alert to neighboring cells to increase their antiviral defenses to prevent the infection from spreading.

24 Mar 2021

Repurposed heart and flu drugs that protect platelets improve survival of septic mice

Despite continued improvements in antibiotics and hospital intensive care, staph sepsis -; a bloodstream infection caused by Staphylococcus aureus bacteria -; still causes severe illness or death in 20 to 30 percent of patients who contract it.

24 Mar 2021

Auto-aggressive immune cells cause liver immune pathology in non-alcoholic steatohepatitis

Non-alcoholic steatohepatitis (NASH), often called 'fatty liver hepatitis', can lead to serious liver damage and liver cancer.

24 Mar 2021

New compound may provide a basis for drug development against COVID-19

SARS-CoV-2, the virus responsible for the COVID-19 pandemic, arrived one year ago and turned our lives upside-down.

24 Mar 2021

Sargramostim drug can also improve memory in people with mild-to-moderate Alzheimer's disease

A new study suggests that Sargramostim, a medication often used to boost white blood cells after cancer treatments, is also effective in treating and improving memory in people with mild-to-moderate Alzheimer's disease.

24 Mar 2021

Detecting SARS-CoV-2 specific IgG antibodies with the Kantaro Covid-SeroKlir Kit

In this interview, Gary Dowthwaite, the Special Projects co-ordinator at EKF Diagnostics, talks to News-Medical about the Kantaro COVID-SeroKlir Kit.

From EKF Diagnostics 24 Mar 2021

Study may lead to more refined approaches for head and neck cancers

By targeting an enzyme that plays a key role in head and neck cancer cells, researchers from the UCLA School of Dentistry were able to significantly slow the growth and spread of tumors in mice and enhance the effectiveness of an immunotherapy to which these types of cancers often become resistant.

24 Mar 2021

Study reveals arsenal used by protozoans to make leishmaniasis more severe

Researchers have succeeded in revealing the arsenal used by protozoans of the genus Leishmania in human cells to make leishmaniasis more severe, especially in cases of the mucocutaneous variety of the disease, which can cause deformations in patients.

24 Mar 2021

Checkpoint inhibition could offer an effective treatment option for patients with rare cancer

Peritoneal mesothelioma is cancer that develops in the lining of the abdomen, which is known as the peritoneum.

24 Mar 2021

People who received flu shot last season had fewer complication of COVID-19

People who received a flu shot last flu season were significantly less likely to test positive for a COVID-19 infection when the pandemic hit, according to a new study.

23 Mar 2021

Genetic study identifies sex-dependent differences in major psychiatric disorders

An analysis of sex differences in the genetics of schizophrenia, bipolar disorder and major depressive disorders indicates that while there is substantial genetic overlap between males and females, there are noticeable sex-dependent differences in how genes related to the central nervous system, immune system, and blood vessels affect people with these disorders.

23 Mar 2021

Scientists develop new diagnostic procedure for pulmonary aspergillosis

Scientists have developed a pioneering new procedure that will help diagnose a potentially lethal fungal lung disease with greater speed and accuracy, and with less distress to the patient.

23 Mar 2021

Computational analysis reveals why new SARS-CoV-2 variants bind better to human cells

All viruses mutate as they make copies of themselves to spread and thrive. SARS-CoV-2, the virus the causes COVID-19, is proving to be no different. There are currently more than 4,000 variants of COVID-19, which has already killed more than 2.7 million people worldwide during the pandemic.

23 Mar 2021

Post-COVID-19 blood clots may be caused by lingering immune response in blood vessels

Serious complications due to blood clots, such as heart attacks and strokes, that are experienced by some COVID-19 survivors may be caused by a lingering immune response in the blood vessels after recovery, suggests a study published today in eLife.

23 Mar 2021

Study reveals a genetic variant linked to COVID-19 severity in young men

A study of young men with COVID-19 has revealed a genetic variant linked to disease severity.

23 Mar 2021

How could AI be used to predict infection outcomes?

Professor Frankel speaks to News-Medical about his latest research that investigated whether AI could be used to predict infection outcomes.

23 Mar 2021

Standardized drying protocol for goldenseal could lead to more predictable health outcomes

Developing a standardized drying protocol for goldenseal could lead to more predictable health applications and outcomes by preserving the alkaloids found in the plant, which is native to Appalachia, according to Penn State researchers, who conducted a new study of the medicinal forest herb.

23 Mar 2021

Most cancer patients with COVID-19 produce antibodies at a rate comparable to general population

Most people with cancer who are infected by the novel coronavirus produce antibodies at a rate comparable to the rest of the population--but their ability to do so depends on their type of cancer and the treatments they've received, according to a new study by researchers at Montefiore Health System and Albert Einstein College of Medicine.

22 Mar 2021

Immune System News and Research

COVID vaccines have only 17% detectable antibodies against SARS-CoV-2 virus

New therapeutic vaccine uses patient's own tumor cells to aid in cancer destruction

Researchers characterize a potential therapeutic target to weaken COVID-19

Repurposed heart and flu drugs that protect platelets improve survival of septic mice

Auto-aggressive immune cells cause liver immune pathology in non-alcoholic steatohepatitis

New compound may provide a basis for drug development against COVID-19

Sargramostim drug can also improve memory in people with mild-to-moderate Alzheimer's disease

Detecting SARS-CoV-2 specific IgG antibodies with the Kantaro Covid-SeroKlir Kit

Study may lead to more refined approaches for head and neck cancers

Study reveals arsenal used by protozoans to make leishmaniasis more severe

Checkpoint inhibition could offer an effective treatment option for patients with rare cancer

People who received flu shot last season had fewer complication of COVID-19

Genetic study identifies sex-dependent differences in major psychiatric disorders

Scientists develop new diagnostic procedure for pulmonary aspergillosis

Computational analysis reveals why new SARS-CoV-2 variants bind better to human cells

Post-COVID-19 blood clots may be caused by lingering immune response in blood vessels

Study reveals a genetic variant linked to COVID-19 severity in young men

How could AI be used to predict infection outcomes?

Standardized drying protocol for goldenseal could lead to more predictable health outcomes

Most cancer patients with COVID-19 produce antibodies at a rate comparable to general population

Immunology eBook

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News